Search results
Noxopharm scales up production of lupus drug SOF-SKN™ to GLP standards
Proactive Investors· 1 day agoNoxopharm Ltd (ASX:NOX, OTC:NOXOF) has reached a major drug development milestone in scaling up...
Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress By Investing.com
Investing.com· 9 hours agoInnate Pharma SA (OTC:IPHYF) (IPHA) discussed its first quarter 2024 financial results and provided...
Lialda interactions: Other medications, alcohol, and more
Medical News Today· 16 hours agoLialda (mesalamine) is a brand-name oral tablet prescribed for ulcerative colitis. Lialda has...
Earnings call: CV Sciences posts a revenue of $4 million By Investing.com
Investing.com· 6 hours agoCV Sciences (OTC:CVSI), a leader in the natural product retail channel, has reported a revenue of $4...
Race Oncology higher as bisantrene is combined with decitabine to enhance killing of multiple cancer...
Proactive Investors· 17 hours agoRace Oncology Ltd (ASX:RAC, OTC:RAONF) is trading higher on findings that combining bisantrene with...
FDA fast track status granted to iECURE neonatal OTC deficiency treatment
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe therapeutic benefits of ECUR-506 have been recognised previously, with the FDA awarding it rare...
Can You Take L-Theanine and Magnesium Together?
Health via Yahoo News· 2 days agoThe pair aren’t well studied together, but research does not indicate that taking them together would be a problem. OTC supplements can vary in quality....
FDA: Cue Health COVID tests may return false positive, negative results, so throw them away
Naples Daily News via Yahoo News· 15 hours ago"Consider retesting using a different COVID-19 test that received FDA authorization if you tested...
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
Reuters via AOL· 6 days agoViatris, formed by the merger of Mylan and Pfizer's Upjohn business, makes generic and key branded drugs such as erectile dysfunction drug Viagra, anti-anxiety medication ...
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose...
WKRN Nashville· 8 hours agoNanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert H. Lurie Comprehensive ...
